Serological analysis of human pandemic influenza (H1N1) in Thailand.
The study was aimed at determining the prevalence of pandemic influenza (H1N1) 2009 among patients with respiratory tract diseases during July-December 2009 using real-time reverse transcription polymerase chain reaction. Haemagglutination inhibition (HI) assay was performed to detect antibody titres against pandemic influenza in 255 medical personnel, 307 members of the general population during the second week of December 2009 in Khon Kaen province, Thailand, and in 100 stored sera collected from people of different age-groups during 2008. The results showed that the pandemic (H1N1) 2009 had occurred during July-December 2009. The results of the HI test after the wave of this outbreak showed that 123 (48%) of the 255 sera collected from the medical personnel, 109 (36%) of the 307 sera obtained from the general population, and only two of the 100 stored sera from 2008 contained antibodies (HI titres > or = 40) against pandemic influenza. Antibody against the pandemic (H1N1) 2009 was found in at least one-third of the population. In conclusion, the prevalence of virus and serological data obtained from the study can be used as the serological background level of the Thai population after the July-December pandemic. Finally, the serological data might be useful for outbreak-prevention and control strategies and for the management of vaccination for the pandemic (H1N1) 2009 in Thailand.
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Slinporn
S
Prachayangprecha
Jarika
J
Makkoch
Sunchai
S
Payungporn
Thaweesak
T
Chieochansin
Chanpim
C
Vuthitanachot
Viboonsuk
V
Vuthitanachot
Apiradee
A
Theamboonlers
Yong
Y
Poovorawan
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007223:Infant; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology / Q000302:isolation & purification*; D007251:Influenza, Human / Q000453:epidemiology* / Q000276:immunology / Q000821:virology; D008297:Male; D008875:Middle Aged; D058873:Pandemics; D012141:Respiratory Tract Infections / Q000453:epidemiology* / Q000276:immunology / Q000821:virology; D013785:Thailand / Q000453:epidemiology; D055815:Young Adult
N Engl J Med. 2009 Jun 18;360(25):2595-8
19423872
Nature. 2009 Aug 20;460(7258):1021-5
19672242
Science. 2008 Apr 18;320(5874):340-6
18420927
N Engl J Med. 2009 Nov 12;361(20):1945-52
19745214
Science. 2009 Jun 19;324(5934):1557-61
19433588
J Virol Methods. 2008 Sep;152(1-2):25-31
18598722
Euro Surveill. 2009 Jun 04;14(22):
19497256
J Clin Microbiol. 1999 Apr;37(4):937-43
10074505
JAMA. 2010 Apr 14;303(14):1383-91
20388894
PLoS Med. 2006 Apr;3(4):e89
16509764
PLoS Med. 2008 Mar 25;5(3):e74
18366252
MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4
19478718
Emerg Infect Dis. 2009 Nov;15(11):1849-50
19891883
N Engl J Med. 2009 Jul 9;361(2):115-9
19474418
N Z Med J. 2009 Jul 24;122(1299):73-7
19684651
PLoS One. 2009 Nov 11;4(11):e7776
19936224
PLoS One. 2008 Jul 16;3(7):e2691
18628983
PLoS Pathog. 2007 Oct 19;3(10):1470-6
17953482
Asian Pac J Allergy Immunol. 2010 Mar;28(1):67-75
20527519
Ann Intern Med. 2009 Oct 6;151(7):437-46
19652172